Câncer de rim: Entendendo o que significa um diagnóstico de carcinoma de células renais | Newswise

Câncer de rim: Entendendo o que significa um diagnóstico de carcinoma de células renais | Newswise

Newswise — ROCHESTER, Minnesota — O carcinoma de células renais é a forma mais comum de câncer de rim. Pode-se levar um tempo para processar completamente um diagnóstico e entender o que ele realmente significa. Desenvolver uma boa compreensão da sua doença — e especialmente do processo diagnóstico — pode ajudá-lo a estabelecer expectativas realistas e a participar…

Read More
Cáncer de riñón: Entendiendo qué significa un diagnóstico de carcinoma de células renales | Newswise

Cáncer de riñón: Entendiendo qué significa un diagnóstico de carcinoma de células renales | Newswise

Newswise — ROCHESTER, Minnesota — El carcinoma de células renales es la forma más común de cáncer de riñón. Se puede tomar un tiempo para procesar completamente un diagnóstico y comprender lo que realmente significa. Desarrollar una buena comprensión de su enfermedad, y especialmente del proceso de diagnóstico, puede ayudarlo a establecer expectativas realistas y a participar activamente…

Read More
Joint Statement From Asn, Era, and Isn: Announcing the Asn-Era-Isn Kidney
Support Initiative | Newswise

Joint Statement From Asn, Era, and Isn: Announcing the Asn-Era-Isn Kidney Support Initiative | Newswise

Newswise — The leadership of the American Society of Nephrology (ASN), the European Renal Association (ERA), and the International Society of Nephrology (ISN) launched the ASN-ERA-ISN Kidney Support Initiative in December 2023. With representatives from all three societies, and coordinated by ERA, the initiative includes: Representatives from ASN• Volunteer ASN: Professor Jeffrey I. Silberzweig, MD,…

Read More
Joint Statement From Asn, Era, and Isn: Announcing the Asn-Era-Isn Kidney
Support Initiative | Newswise

Yo-Yo Dieting May Significantly Increase Kidney Disease Risk in People with Type 1 Diabetes | Newswise

Newswise — WASHINGTON—Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other traditional risk factors, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Yo-yo dieting is…

Read More
A Diabetes, Heart Failure, and Kidney Disease Medication is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes | Newswise

A Diabetes, Heart Failure, and Kidney Disease Medication is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes | Newswise

EMBARGOED UNTIL FEBRUARY 14, 2025 6:30PM EST                 Contact:  Ilana Nikravesh                 Mount Sinai Press Office                  212-241-9200                    [email protected] A Diabetes, Heart Failure, and Kidney Disease Medication is the First of Its Kind to…

Read More
Joint Statement From Asn, Era, and Isn: Announcing the Asn-Era-Isn Kidney
Support Initiative | Newswise

Increased Cancer Risk for Kidney Transplant Recipients Linked to Epstein-Barr Virus | Newswise

Newswise — PHILADELPHIA— More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious mononucleosis (“mono”) and for its association with several cancers and autoimmune diseases. Kidney transplant patients who’ve…

Read More
Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer | Newswise

Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer | Newswise

Newswise — Boston – Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine. The vaccines were administered after surgery to remove…

Read More
Joint Statement From Asn, Era, and Isn: Announcing the Asn-Era-Isn Kidney
Support Initiative | Newswise

Phase 2 LITESPARK-003 Results Suggest Continued Study of Novel First-Line Combo for Advanced Kidney Cancer | Newswise

RESEARCH SUMMARY Newswise — Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study Publication: The Lancet Oncology – January 2025 Dana-Farber Cancer Institute authors: Toni K. Choueiri, MD Summary: In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute’s…

Read More
Hackensack University Medical Center Launches Educational Website for People with Kidney Cancer
 | Newswise

Hackensack University Medical Center Launches Educational Website for People with Kidney Cancer | Newswise

Newswise — Members of the Department of Urology at Hackensack University Medical Center have launched the Kidney Cancer Resource Center, an online educational tool for people diagnosed with renal cell carcinoma, a type of kidney cancer. The website provides information to help them better understand the disease and make treatment decisions based on the findings…

Read More